Immunoglobulin G-dependent enhancement of the infection with Coxsackievirus B4 in a murine system. Issue 5 (3rd July 2016)

• Record Type: Journal Article
• Authors: Elmastour, Firas; Jaidane, Hela; Aguech-Oueslati, Leila; Benkahla, Mehdi Ayech; Aouni, Mahjoub; Gharbi, Jawhar; Sane, Famara; Hober, Didier
• Is Part Of: Virulence. Volume 7:Issue 5(2016)
• Page Start: 527
• Page End: 535
• Publication Date: 2016-07-03
• Subjects: antiviral activity -- enteroviral RNA -- enterovirus -- in vitro -- serum -- spleen cells; Virulence (Microbiology) -- Periodicals; Bacterial diseases -- Periodicals; Molecular microbiology -- Periodicals; 579.05
• DOI: 10.1080/21505594.2016.1152442
• Languages: English
• ISSNs: 2150-5608

Abstract

ABSTRACT: It was demonstrated that specific IgG can enhance the infection with CV-B4, in vitro, in the human system. This enhancement could be involved in the pathophysiology of CV-B4 induced diseases. To investigate further the role of enhancing IgG in the infection with CV-B4 E2 in vivo, animal models are needed. Therefore, it was decided to assess whether inoculation of CV-B4 E2 to mice results in the appearance of IgG able to enhance the infection with this virus. Swiss albino mice were inoculated with CV-B4 E2 intraperitoneally. Serum samples were obtained from tail vein blood collected from day 0 to day 80 p.i. IgG were isolated by Protein G affinity chromatography. Seroneutralisation assays were carried out. In total murine spleen cells cultures inoculated with CV-B4 E2 mixed with various dilutions of serum or IgG samples, the enhancing activity was assayed through i) the antiviral activity titer of supernatants ii) the detection of intracellular viral RNA by RT-PCR iii) the level of infectious particles in supernatants. In most serum samples (76/105), neutralizing and enhancing activities were detected peaking between days 14 and 30 p.i and were higher in sera from mice inoculated with 2.10 6 TCID50 units than with lower doses. The enhancing activity was due to the IgG-enriched fraction of serum from CV-B4 E2 infected animals but not from control animals. These data show that IgG from immune mice can enhance the infection of splenocytes with CV-B4 E2 in vitro and open the way to explore whether such an enhancing activity can play a role in vivo .